论文部分内容阅读
用此法治疗30例经剖腹探查确定无法切除的原发性肝癌,治疗有效率为83.3%(25/30),6个月生存率为100%,1年生存率为56.7%(17/30),2年生存率为30.0%(9/30),3年生存率为16.7%(5/30)。30例病人均行肝固有动脉结扎无手术死亡。灌注化疗过程中毒副反应比全身化疗轻,亦未发现其它严重并发症。作者认为此疗法对不能切除的原发性肝癌患者有一定疗效。
This method was used to treat 30 cases of unresectable primary liver cancer after laparotomy. The effective rate was 83.3% (25/30). The 6-month survival rate was 100%. The 1-year survival rate was 56.7% (17/30). The 2-year survival rate was 30.0% (9/30) and the 3-year survival rate was 16.7% (5/30). All 30 patients underwent hepatic artery ligation without operative mortality. The side effects of infusion chemotherapy were lighter than those of systemic chemotherapy, and no other serious complications were found. The authors believe that this therapy has a certain effect on unresectable primary liver cancer patients.